CGVYX
Price
$25.47
Change
+$0.01 (+0.04%)
Updated
Jun 18 closing price
Net Assets
16.71B
CWGCX
Price
$67.82
Change
+$0.05 (+0.07%)
Updated
Jun 18 closing price
Net Assets
130.8B
Interact to see
Advertisement

CGVYX vs CWGCX

Header iconCGVYX vs CWGCX Comparison
Open Charts CGVYX vs CWGCXBanner chart's image
American Funds Global Insight 529-A
Price$25.47
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets16.71B
American Funds Capital World Gr&Inc C
Price$67.82
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets130.8B
CGVYX vs CWGCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CGVYX vs. CWGCX commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGVYX is a StrongBuy and CWGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. CGVYX (16.7B). CWGCX (0.87) and CGVYX (0.86) have matching dividends . CGVYX was incepted earlier than CWGCX: CGVYX (6 years) vs CWGCX (24 years). CWGCX (1.49) is less costly to investors than CGVYX (0.81). CWGCX is a more actively managed with annual turnover of: 27.00 vs. CGVYX (21.00). CGVYX (250) and CWGCX (250) have matching initial minimum investment requirements. CGVYX annual gain was more profitable for investors over the last year : 11.55 vs. CWGCX (4.92). CGVYX return over 5 years is better than : 63.31 vs. CWGCX (45.73).
CGVYXCWGCXCGVYX / CWGCX
Total Expense Ratio0.811.4954%
Annual Report Gross Expense Ratio0.811.4954%
Fund Existence6 years24 years-
Gain YTD9.3138.602108%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets16.7B131B13%
Annual Yield % from dividends0.860.8799%
Returns for 1 year11.554.92235%
Returns for 3 years53.0143.91121%
Returns for 5 years63.3145.73138%
Returns for 10 yearsN/A48.13-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDSA2.040.03
+1.24%
Edesa Biotech
LDOS148.35-1.04
-0.70%
Leidos Holdings
LFCR6.71-0.10
-1.47%
Lifecore Biomedical
CGC1.29-0.03
-2.27%
Canopy Growth Corp
UA5.86-0.17
-2.82%
Under Armour